C C Bancroft
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
Papers in
-
- NF-κB Signaling Pathways 3
- Co-authors
- Ning T. YehJohn B. SunwooCarter Van WaesZhong ChenGuo‐Chung DongEdward A. SausvilleJulian AdamsPeter J. Elliott
- Journals
- International Journal of Cancer (2 papers)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
C C Bancroft
6 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 400
- Oncology 503
- Hepatology 103
- Molecular Biology 774
- Immunology 211
Countries citing papers authored by C C Bancroft
This map shows the geographic impact of C C Bancroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C C Bancroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C C Bancroft more than expected).
Fields of papers citing papers by C C Bancroft
This network shows the impact of papers produced by C C Bancroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C C Bancroft. The network helps show where C C Bancroft may publish in the future.
Co-authorship network
The 19 scholars most cited alongside C C Bancroft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 201 | |
| 2 | IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. | 2001 | 193 |
| 3 | Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. | 2001 | 393 |
| 4 | Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. | 2001 | 228 |
| 5 | Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. | 2001 | 160 |
| 6 | 2000 | 28 |
About C C Bancroft
C C Bancroft is a scholar working on Cancer Research, Hepatology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 6 papers that have together received 1.2k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (3 papers), Immune Response and Inflammation (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), HER2/EGFR in Cancer Research (1 paper), interferon and immune responses (1 paper), Cell death mechanisms and regulation (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Cancer Research (400 citations), Oncology (503 citations), Hepatology (103 citations), Molecular Biology (774 citations) and Immunology (211 citations). C C Bancroft has collaborated with scholars based in United States. Frequent co-authors include Ning T. Yeh, John B. Sunwoo, Carter Van Waes, Zhong Chen, Zhong Chen, Carter Van Waes, Guo‐Chung Dong, Edward A. Sausville, Julian Adams and Peter J. Elliott. Their work appears in journals such as International Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.